Evidence map›Paper›PMID 31970803›Full record

ArticleAnnals of neurology2020

Novel Recessive TNNT1 Congenital Core-Rod Myopathy in French Canadians.

David Pellerin, Asli Aykanat, Benjamin Ellezam, Emily C Troiano, Jason Karamchandani, Marie-Josée Dicaire, Marc Petitclerc, Rebecca Robertson, Xavier Allard-Chamard, Denis Brunet and 7 more

Open access · greenAbstract read
In one paragraph

Article in Annals of neurology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.7field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 26 citations in OpenAlex.

  1. A homozygous single-nucleotide variant inJournal of neuromuscular diseases · 2025
    Article
  2. Article
  3. Article
  4. Article
  5. Observational
  6. Muscle magnetic resonance imaging involvement patterns in nemaline myopathies.Annals of clinical and translational neurology · 2023
    Article
  7. Article
  8. Review
  9. Biallelic Pathogenic Variants inNeurology. Genetics · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 10 institutions in 2 countries.

David PellerinDepartment of Neurology and Neurosurgery, Montreal Neurological Hospital and Institute, McGill University, Montreal, Quebec, Canada.ORCID 0000-0002-5807-995X
Asli AykanatDivision of Genetics and Genomics, The Manton Center for Orphan Disease Research, Boston Children's Hospital, Harvard Medical School, Boston, MA.ORCID 0000-0002-0862-4307
Benjamin EllezamDepartment of Pathology, Centre Hospitalier Universitaire Sainte-Justine, Université de Montréal, Montreal, Quebec, Canada.
Emily C TroianoDivision of Genetics and Genomics, The Manton Center for Orphan Disease Research, Boston Children's Hospital, Harvard Medical School, Boston, MA.
Jason KaramchandaniDepartment of Pathology, Montreal Neurological Hospital and Institute, McGill University, Montreal, Quebec, Canada.
Marie-Josée DicaireDepartment of Neurology and Neurosurgery, Montreal Neurological Hospital and Institute, McGill University, Montreal, Quebec, Canada.
Marc PetitclercDepartment of Neurology, Hôpital Hôtel-Dieu de Lévis, Lévis, Quebec, Canada.
Rebecca RobertsonDepartment of Neurology and Neurosurgery, Montreal Neurological Hospital and Institute, McGill University, Montreal, Quebec, Canada.
Xavier Allard-ChamardDepartment of Neurology and Neurosurgery, Montreal Neurological Hospital and Institute, McGill University, Montreal, Quebec, Canada.
Denis BrunetDepartment of Neurology, Hôpital de l'Enfant Jésus, Université Laval, Quebec City, Quebec, Canada.
Chamindra G KonersmanDepartment of Neurosciences, University of California, San Diego, San Diego, CA.
Jean MathieuFaculty of Medicine and Health Sciences, Université de Sherbrooke, Sherbrooke, Quebec, Canada.
Jodi Warman ChardonDepartment of Neurosciences, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
Vandana A GuptaDivision of Genetics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
Alan H BeggsDivision of Genetics and Genomics, The Manton Center for Orphan Disease Research, Boston Children's Hospital, Harvard Medical School, Boston, MA.ORCID 0000-0001-8818-0568
Bernard BraisDepartment of Neurology and Neurosurgery, Montreal Neurological Hospital and Institute, McGill University, Montreal, Quebec, Canada.
Nicolas ChrestianDepartment of Child Neurology, Centre Hospitalier de l'Université Laval et Centre Mère-Enfant Soleil, Université Laval, Quebec City, Quebec, Canada.
Montreal Neurological Institute and Hospital · CABoston Children's Hospital · USBrigham and Women's Hospital · USCégep de Lévis · CACentre hospitalier de l'Université Laval · CACentre Hospitalier Universitaire Sainte-Justine · CAHôpital de l'Enfant-Jésus · CAOttawa Hospital · CAUniversité de Sherbrooke · CAUniversity of California San Diego · US

Funding

VectorP30CA006516 · NCI · DANA-FARBER CANCER INSTITUTE · PI JENNIFER W MACK · 1985 to 2026
$330.6M
Mouse Neurodevelopmental Behavior CoreU54HD090255 · NICHD · BOSTON CHILDREN'S HOSPITAL · PI POMEROY, SCOTT LOREN · 2016 to 2020
$5.2M
Genetic screening and therapies for nemaline myopathiesR01HD075802 · NICHD · BOSTON CHILDREN'S HOSPITAL · PI BEGGS, ALAN H. · 2014 to 2018
$1.8M
NCI NIH HHS P30 CA006516NICHD NIH HHS R01 HD075802NICHD NIH HHS U54 HD090255
6 · The paper itself

Abstract

objectiveRecessive null variants of the slow skeletal muscle troponin T1 (TNNT1) gene are a rare cause of nemaline myopathy that is fatal in infancy due to respiratory insufficiency. Muscle biopsy shows rods and fiber type disproportion. We report on 4 French Canadians with a novel form of recessive congenital TNNT1 core-rod myopathy.

methodsPatients underwent full clinical characterization, lower limb magnetic resonance imaging (MRI), muscle biopsy, and genetic testing. A zebrafish loss-of-function model using morpholinos was created to assess the pathogenicity of the identified variant. Wild-type or mutated human TNNT1 mRNAs were coinjected with morpholinos to assess their abilities to rescue the morphant phenotype.

resultsThree adults and 1 child shared a novel missense homozygous variant in the TNNT1 gene (NM_003283.6: c.287T > C; p.Leu96Pro). They developed from childhood very slowly progressive limb-girdle weakness with rigid spine and disabling contractures. They suffered from restrictive lung disease requiring noninvasive mechanical ventilation in 3 patients, as well as recurrent episodes of rhabdomyolysis triggered by infections, which were relieved by dantrolene in 1 patient. Older patients remained ambulatory into their 60s. MRI of the leg muscles showed fibrofatty infiltration predominating in the posterior thigh and the deep posterior leg compartments. Muscle biopsies showed multiminicores and lobulated fibers, rods in half the patients, and no fiber type disproportion. Wild-type TNNT1 mRNA rescued the zebrafish morphants, but mutant transcripts failed to do so.

interpretationThis study expands the phenotypic spectrum of TNNT1 myopathy and provides functional evidence for the pathogenicity of the newly identified missense mutation. ANN NEUROL 2020;87:568-583.

Indexed as

AnimalsChildFemaleGene Knockdown TechniquesHumansMagnetic Resonance ImagingMaleMiddle AgedMorpholinosMuscle, SkeletalMyopathies, NemalineRhabdomyolysisRNA, MessengerTroponin TZebrafishMorpholinosRNA, MessengerTroponin T

Identifiers

PMID31970803
PMCPMC7078025
OpenAlexW3000840952

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.